{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:28:37Z","timestamp":1793410117306,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006516","name":"Bertil H\u00e5llstens Forskningsstiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006516","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cerebrospinal fluid (CSF) biomarkers play an important role in diagnosing Alzheimer\u2019s disease (AD) which is characterized by amyloid-\u03b2 (A\u03b2) amyloidosis. Here, we used two <jats:italic>App<\/jats:italic> knock-in mouse models, <jats:italic>App<\/jats:italic><jats:sup><jats:italic>NL-F\/NL-F<\/jats:italic><\/jats:sup> and <jats:italic>App<\/jats:italic><jats:sup><jats:italic>NL-G-F\/NL-G-F<\/jats:italic><\/jats:sup>, exhibiting AD-like A\u03b2 pathology to analyze how the brain pathologies translate to CSF proteomes by label-free mass spectrometry (MS). This identified several extracellular matrix (ECM) proteins as significantly altered in <jats:italic>App<\/jats:italic> knock-in mice. Next, we compared mouse CSF proteomes with previously reported human CSF MS results acquired from patients across the AD spectrum. Intriguingly, the ECM protein decorin was similarly and significantly increased in both <jats:italic>App<\/jats:italic><jats:sup><jats:italic>NL-F\/NL-F<\/jats:italic><\/jats:sup> and <jats:italic>App<\/jats:italic><jats:sup><jats:italic>NL-G-F\/NL-G-F<\/jats:italic><\/jats:sup> mice, strikingly already at three months of age in the <jats:italic>App<\/jats:italic><jats:sup><jats:italic>NL-F\/NL-F<\/jats:italic><\/jats:sup> mice and preclinical AD subjects having abnormal CSF-A\u03b242 but normal cognition. Notably, in this group of subjects, CSF-decorin levels positively correlated with CSF-A\u03b242 levels indicating that the change in CSF-decorin is associated with early A\u03b2 amyloidosis. Importantly, receiver operating characteristic analysis revealed that CSF-decorin can predict a specific AD subtype having innate immune activation and potential choroid plexus dysfunction in the brain. Consistently, in <jats:italic>App<\/jats:italic><jats:sup><jats:italic>NL-F\/NL-F<\/jats:italic><\/jats:sup> mice, increased CSF-decorin correlated with both A\u03b2 plaque load and with decorin levels in choroid plexus. In addition, a low concentration of human A\u03b242 induces decorin secretion from mouse primary neurons. Interestingly, we finally identify decorin to activate neuronal autophagy through enhancing lysosomal function. Altogether, the increased CSF-decorin levels occurring at an early stage of A\u03b2 amyloidosis in the brain may reflect pathological changes in choroid plexus, present in a subtype of AD subjects.<\/jats:p>","DOI":"10.1186\/s40478-022-01398-5","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T12:11:18Z","timestamp":1656936678000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Increased CSF-decorin predicts brain pathological changes driven by Alzheimer\u2019s A\u03b2 amyloidosis"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5184-4172","authenticated-orcid":false,"given":"Richeng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Una","family":"Smailovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazal","family":"Haytural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty M.","family":"Tijms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Mihai","family":"Haret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganna","family":"Shevchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gefei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Abelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Gobom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Frykman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Watamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sasaguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi C.","family":"Saido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Jelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stina","family":"Syv\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter Jelle","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6450-0870","authenticated-orcid":false,"given":"Per","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"issue":"Pt 9","key":"1398_CR1","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/brain\/awt188","volume":"136","author":"JB Toledo","year":"2013","unstructured":"Toledo JB et al (2013) Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre. Brain 136(Pt 9):2697\u20132706","journal-title":"Brain"},{"issue":"11","key":"1398_CR2","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948070","volume":"20","author":"U Lendahl","year":"2019","unstructured":"Lendahl U, Nilsson P, Betsholtz C (2019) Emerging links between cerebrovascular and neurodegenerative diseases\u2014a special role for pericytes. EMBO Rep 20(11):e48070","journal-title":"EMBO Rep"},{"issue":"6","key":"1398_CR3","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.neurobiolaging.2007.01.008","volume":"29","author":"MO Dietrich","year":"2008","unstructured":"Dietrich MO et al (2008) Megalin mediates the transport of leptin across the blood-CSF barrier. Neurobiol Aging 29(6):902\u2013912","journal-title":"Neurobiol Aging"},{"issue":"10","key":"1398_CR4","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1212\/WNL.57.10.1763","volume":"57","author":"GD Silverberg","year":"2001","unstructured":"Silverberg GD et al (2001) The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer\u2019s type. Neurology 57(10):1763\u20131766","journal-title":"Neurology"},{"issue":"4","key":"1398_CR5","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-180098","volume":"63","author":"Z Cai","year":"2018","unstructured":"Cai Z et al (2018) Role of blood\u2013brain barrier in Alzheimer\u2019s disease. J Alzheimers Dis 63(4):1223\u20131234","journal-title":"J Alzheimers Dis"},{"key":"1398_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","volume":"97","author":"AD Theocharis","year":"2016","unstructured":"Theocharis AD et al (2016) Extracellular matrix structure. Adv Drug Deliv Rev 97:4\u201327","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"1398_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/nan.12295","volume":"43","author":"FX Lepelletier","year":"2017","unstructured":"Lepelletier FX et al (2017) Early changes in extracellular matrix in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 43(2):167\u2013182","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"10","key":"1398_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.bbadis.2008.07.008","volume":"1782","author":"CD Aluise","year":"2008","unstructured":"Aluise CD, Sowell RA, Butterfield DA (2008) Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer\u2019s disease. Biochim Biophys Acta 1782(10):549\u2013558","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"1398_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow K, Zetterberg H (2018) Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future. J Intern Med 284(6):643\u2013663","journal-title":"J Intern Med"},{"issue":"7","key":"1398_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B et al (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol 15(7):673\u2013684","journal-title":"Lancet Neurol"},{"issue":"5","key":"1398_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T et al (2014) Single App knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci 17(5):661\u2013663","journal-title":"Nat Neurosci"},{"issue":"12","key":"1398_CR12","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1093\/brain\/awaa325","volume":"143","author":"BM Tijms","year":"2020","unstructured":"Tijms BM et al (2020) Pathophysiological subtypes of Alzheimer\u2019s disease based on cerebrospinal fluid proteomics. Brain 143(12):3776\u20133792","journal-title":"Brain"},{"issue":"24","key":"1398_CR13","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat C et al (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94(24):13287\u201313292","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1398_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neurobiolaging.2004.12.007","volume":"27","author":"A Lord","year":"2006","unstructured":"Lord A et al (2006) The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. Neurobiol Aging 27(1):67\u201377","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1398_CR15","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/j.1742-4658.2008.06862.x","volume":"276","author":"DM Walsh","year":"2009","unstructured":"Walsh DM et al (2009) A facile method for expression and purification of the Alzheimer\u2019s disease-associated amyloid beta-peptide. FEBS J 276(5):1266\u20131281","journal-title":"FEBS J"},{"issue":"1","key":"1398_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/40.1.1370306","volume":"40","author":"AD Snow","year":"1992","unstructured":"Snow AD et al (1992) Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer\u2019s disease. J Histochem Cytochem 40(1):105\u2013113","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"1398_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M et al (2000) Gene ontology: tool for the unification of biology The Gene Ontology Consortium. Nat Genet 25(1):25\u201329","journal-title":"Nat Genet"},{"issue":"D1","key":"1398_CR18","doi-asserted-by":"publisher","first-page":"D330","DOI":"10.1093\/nar\/gky1055","volume":"47","author":"TGO Resource","year":"2019","unstructured":"Resource TGO (2019) 20 years and still GOing strong. Nucleic Acids Res 47(D1):D330-d338","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1398_CR19","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gky1038","volume":"47","author":"H Mi","year":"2019","unstructured":"Mi H et al (2019) PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res 47(D1):D419-d426","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1398_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13195-018-0396-5","volume":"10","author":"I Bos","year":"2018","unstructured":"Bos I et al (2018) The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics. Alzheimers Res Ther 10(1):64","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"1398_CR21","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1021\/pr500893m","volume":"13","author":"TS Batth","year":"2014","unstructured":"Batth TS, Francavilla C, Olsen JV (2014) Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics. J Proteome Res 13(12):6176\u20136186","journal-title":"J Proteome Res"},{"issue":"D1","key":"1398_CR22","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y et al (2019) The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res 47(D1):D442\u2013D450","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1398_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","volume":"16","author":"H Heberle","year":"2015","unstructured":"Heberle H et al (2015) InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinform 16(1):169","journal-title":"BMC Bioinform"},{"key":"1398_CR24","unstructured":"Oliveros JC, Venny. An interactive tool for comparing lists with Venn's diagrams. 2007\u20132015."},{"issue":"7","key":"1398_CR25","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.3390\/ijms20071632","volume":"20","author":"MA Erickson","year":"2019","unstructured":"Erickson MA, Banks WA (2019) Age-associated changes in the immune system and blood\u2013brain barrier functions. Int J Mol Sci 20(7):1632","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1398_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","volume":"30","author":"AJ Farrall","year":"2009","unstructured":"Farrall AJ, Wardlaw JM (2009) Blood\u2013brain barrier: ageing and microvascular disease\u2014systematic review and meta-analysis. Neurobiol Aging 30(3):337\u2013352","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1398_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A et al (2015) Blood\u2013brain barrier breakdown in the aging human hippocampus. Neuron 85(2):296\u2013302","journal-title":"Neuron"},{"issue":"34","key":"1398_CR28","doi-asserted-by":"publisher","first-page":"12754","DOI":"10.1074\/jbc.RA119.009487","volume":"294","author":"T Saito","year":"2019","unstructured":"Saito T et al (2019) Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation. J Biol Chem 294(34):12754\u201312765","journal-title":"J Biol Chem"},{"issue":"9","key":"1398_CR29","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.neurobiolaging.2007.11.022","volume":"30","author":"O Philipson","year":"2009","unstructured":"Philipson O et al (2009) A highly insoluble state of Abeta similar to that of Alzheimer\u2019s disease brain is found in Arctic APP transgenic mice. Neurobiol Aging 30(9):1393\u20131405","journal-title":"Neurobiol Aging"},{"issue":"39","key":"1398_CR30","doi-asserted-by":"publisher","first-page":"16211","DOI":"10.1074\/jbc.M116.769950","volume":"292","author":"T Neill","year":"2017","unstructured":"Neill T et al (2017) Decorin-evoked paternally expressed gene 3 (PEG3) is an upstream regulator of the transcription factor EB (TFEB) in endothelial cell autophagy. J Biol Chem 292(39):16211\u201316220","journal-title":"J Biol Chem"},{"key":"1398_CR31","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20140141","author":"YY Zhou","year":"2015","unstructured":"Zhou YY et al (2015) MAPK\/JNK signalling: a potential autophagy regulation pathway. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20140141"},{"issue":"7693","key":"1398_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature25739","volume":"554","author":"M Vanlandewijck","year":"2018","unstructured":"Vanlandewijck M et al (2018) A molecular atlas of cell types and zonation in the brain vasculature. Nature 554(7693):475\u2013480","journal-title":"Nature"},{"issue":"147","key":"1398_CR33","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med 4(147):147ra111","journal-title":"Sci Transl Med"},{"issue":"6","key":"1398_CR34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/archneur.56.6.673","volume":"56","author":"N Andreasen","year":"1999","unstructured":"Andreasen N et al (1999) Cerebrospinal fluid beta-amyloid(1\u201342) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 56(6):673\u2013680","journal-title":"Arch Neurol"},{"issue":"2","key":"1398_CR35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA et al (2019) Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 25(2):270\u2013276","journal-title":"Nat Med"},{"key":"1398_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2016.06.006","volume":"45","author":"HJ van de Haar","year":"2016","unstructured":"van de Haar HJ et al (2016) Neurovascular unit impairment in early Alzheimer\u2019s disease measured with magnetic resonance imaging. Neurobiol Aging 45:190\u2013196","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1398_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1148\/radiol.2016152244","volume":"281","author":"HJ van de Haar","year":"2016","unstructured":"van de Haar HJ et al (2016) Blood\u2013brain barrier leakage in patients with early Alzheimer disease. Radiology 281(2):527\u2013535","journal-title":"Radiology"},{"issue":"9\u201310","key":"1398_CR38","doi-asserted-by":"publisher","first-page":"542","DOI":"10.2119\/2007-00034.Bellucci","volume":"13","author":"C Bellucci","year":"2007","unstructured":"Bellucci C et al (2007) Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer\u2019s disease. Mol Med 13(9\u201310):542\u2013550","journal-title":"Mol Med"},{"issue":"28","key":"1398_CR39","doi-asserted-by":"publisher","first-page":"E2582","DOI":"10.1073\/pnas.1305732110","volume":"110","author":"S Buraschi","year":"2013","unstructured":"Buraschi S et al (2013) Decorin causes autophagy in endothelial cells via Peg3. Proc Natl Acad Sci USA 110(28):E2582\u2013E2591","journal-title":"Proc Natl Acad Sci USA"},{"key":"1398_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.matbio.2013.12.011","volume":"34","author":"A Goyal","year":"2014","unstructured":"Goyal A et al (2014) Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells. Matrix Biol 34:46\u201354","journal-title":"Matrix Biol"},{"issue":"8","key":"1398_CR41","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1074\/jbc.M113.512566","volume":"289","author":"T Neill","year":"2014","unstructured":"Neill T et al (2014) Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor \u03b3 coactivator-1\u03b1 (PGC-1\u03b1) and mitostatin. J Biol Chem 289(8):4952\u20134968","journal-title":"J Biol Chem"},{"issue":"7","key":"1398_CR42","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/2211-5463.12076","volume":"6","author":"T Yao","year":"2016","unstructured":"Yao T et al (2016) Decorin-mediated inhibition of the migration of U87MG glioma cells involves activation of autophagy and suppression of TGF-beta signaling. FEBS Open Bio 6(7):707\u2013719","journal-title":"FEBS Open Bio"},{"issue":"6","key":"1398_CR43","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.3892\/etm.2016.3908","volume":"12","author":"H Zhao","year":"2016","unstructured":"Zhao H et al (2016) Expression of decorin in intestinal tissues of mice with inflammatory bowel disease and its correlation with autophagy. Exp Ther Med 12(6):3885\u20133892","journal-title":"Exp Ther Med"},{"issue":"14","key":"1398_CR44","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1038\/onc.2009.487","volume":"29","author":"S Shimizu","year":"2010","unstructured":"Shimizu S et al (2010) Involvement of JNK in the regulation of autophagic cell death. Oncogene 29(14):2070\u20132082","journal-title":"Oncogene"},{"issue":"2","key":"1398_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","volume":"64","author":"RA Nixon","year":"2005","unstructured":"Nixon RA et al (2005) Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 64(2):113\u2013122","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"1398_CR46","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.neuron.2022.01.017","volume":"110","author":"A Fleming","year":"2022","unstructured":"Fleming A et al (2022) The different autophagy degradation pathways and neurodegeneration. Neuron 110(6):935\u2013966","journal-title":"Neuron"},{"key":"1398_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.878303","volume":"14","author":"R Jiang","year":"2022","unstructured":"Jiang R et al (2022) Autophagy impairment in App knock-in Alzheimer\u2019s model mice. Front Aging Neurosci 14:878303","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1398_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1083\/jcb.200505082","volume":"171","author":"WH Yu","year":"2005","unstructured":"Yu WH et al (2005) Macroautophagy\u2014a novel Beta-amyloid peptide-generating pathway activated in Alzheimer\u2019s disease. J Cell Biol 171(1):87\u201398","journal-title":"J Cell Biol"},{"key":"1398_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101307","volume":"67","author":"A Kobro-Flatmoen","year":"2021","unstructured":"Kobro-Flatmoen A et al (2021) Re-emphasizing early Alzheimer\u2019s disease pathology starting in select entorhinal neurons, with a special focus on mitophagy. Ageing Res Rev 67:101307","journal-title":"Ageing Res Rev"},{"issue":"1","key":"1398_CR50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41551-021-00819-5","volume":"6","author":"C Xie","year":"2022","unstructured":"Xie C et al (2022) Amelioration of Alzheimer\u2019s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. Nat Biomed Eng 6(1):76\u201393","journal-title":"Nat Biomed Eng"},{"issue":"3","key":"1398_CR51","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/cancers14030804","volume":"14","author":"T Neill","year":"2022","unstructured":"Neill T, Iozzo RV (2022) The role of decorin proteoglycan in mitophagy. Cancers (Basel) 14(3):804","journal-title":"Cancers (Basel)"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01398-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01398-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01398-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T13:03:43Z","timestamp":1656939823000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01398-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1398"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01398-5","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"assertion":[{"value":"10 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HZ has served at scientific advisory boards and\/or as a consultant for Abbvie, Alector, Annexon, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Pinteon Therapeutics, Red Abbey Labs, Passage Bio, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}